Partnering for Success

On May 7, 2018, Impax Laboratories, Inc. combined with Amneal Pharmaceuticals, Inc. (NYSE:AMRX) to create a dynamic company powered by a robust U.S. generics business and growing branded franchise. Today, we are working to integrate our business into the new Amneal and are excited about our future as one company.

We continually look to forge creative business collaborations and/or M&A opportunities that enhance the depth and breadth of our business and align with our mission, values and goals.

Our Amneal + Impax Corporate Development team has in-depth scientific, financial, analytical and integration knowledge, bringing a broad range of expertise to develop flexible, innovative partnerships. We have a proven track record in:

  • Mergers and Acquisitions
  • Co-promotion agreements
  • Co-development partnerships
  • Distribution collaborations
  • Licensing agreements

If you would like to connect with us about a potential collaboration, please contact our Corporate Development team at